ABTEarnings Release财报快讯SEC sourceSEC 来源Source link原始来源August 6, 20262026/8/6by InvestLog AIInvestLog AI 整理

Abbott Laboratories (ABT) 2026 Q2 period ended 2026-06-30 financial resultsAbbott Laboratories (ABT) 2026 Q2 period ended 2026-06-30 财报发布

Key Results

Abbott Laboratories reported revenue $12.6B, operating profit $1.8B, net income $928M, operating margin 14.2%.

Profitability and Cash Flow

Period: 2026 Q2 period ended 2026-06-30

Revenue: $12.6B; YoY: +13.0%; QoQ: +12.8%

Gross profit: $7.3B; Gross margin: 58.0%

Operating income: $1.8B; Operating margin: 14.2%; YoY: -13.2%; QoQ: -3.3%

Net income: $928M; GAAP diluted EPS: $0.53; YoY: -47.8%; QoQ: -13.8%

Operating cash flow: $2.5B; Capex: $399M; Free cash flow: $2.1B

Cash: $5.1B; Total debt: $32.6B; Net debt: $27.5B

Official release: 10-Q

核心结果

Abbott Laboratories 公布2026 Q2 period ended 2026-06-30财报：营收 $12.6B，营业利润 $1.8B，净利润 $928M，营业利润率 14.2%。

财务指标

期间：2026 Q2 period ended 2026-06-30

营收：$12.6B；同比：+13.0%；环比：+12.8%

毛利润：$7.3B；毛利率：58.0%

经营利润：$1.8B；经营利润率：14.2%；同比：-13.2%；环比：-3.3%

净利润：$928M；GAAP 稀释 EPS：$0.53；同比：-47.8%；环比：-13.8%

经营现金流：$2.5B；资本开支：$399M；自由现金流：$2.1B

现金：$5.1B；总债务：$32.6B；净债务：$27.5B

View ABT stock details ->查看 ABT 个股详情 ->

This earnings research was prepared from company results, regulatory filings, and financial statements. It is for informational purposes only and does not constitute investment advice.这篇财报研究基于公司业绩公告、监管文件和财务报表整理。内容仅供参考，不构成投资建议。

Abbott Laboratories (ABT) 2026 Q2 period ended 2026-06-30 financial resultsAbbott Laboratories (ABT) 2026 Q2 period ended 2026-06-30 财报发布

Key Results

Profitability and Cash Flow

核心结果

财务指标

Related research相关阅读